Lynn Rogers-Lee

Lynn Rogers-Lee is an experienced analytical biochemist currently employed at BioAegis Therapeutics, Inc. since 2022, specializing in various assays for drug product development targeting infectious, inflammatory, and degenerative diseases. Previous roles include Scientist III at Merck, focusing on mAb formulation characterizations, and Senior Scientist at PDS Biotechnology Corporation, where method development for protein and peptide drugs was conducted. Lynn's extensive background in biochemistry and analytical techniques spans positions at prominent companies such as McNeil Consumer Healthcare, Janssen Pharmaceuticals, Bristol-Myers Squibb, and Schering-Plough Research Institute, contributing to drug discovery and development through methods including ELISA, HPLC, and LC-MS/MS. Lynn holds an MS in Biochemistry from New York Medical College and a BS in Chemistry/Health Science from Brooklyn College.